wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33422543-28FB3CA5-DB8D-45A3-8D8B-1E384718F9D5
Q33422543-28FB3CA5-DB8D-45A3-8D8B-1E384718F9D5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33422543-28FB3CA5-DB8D-45A3-8D8B-1E384718F9D5
Phase 1 study of the safety, pharmacokinetics, and antitumour activity of the BCL2 inhibitor navitoclax in combination with rituximab in patients with relapsed or refractory CD20+ lymphoid malignancies
P407
Q33422543-28FB3CA5-DB8D-45A3-8D8B-1E384718F9D5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33422543-28FB3CA5-DB8D-45A3-8D8B-1E384718F9D5
rank
NormalRank
type
BestRank
Statement
P407
English